We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Injectable Biologic Therapy Reduces Triglycerides

News   Nov 16, 2016

 
Injectable Biologic Therapy Reduces Triglycerides
 
 
Advertisement
 

RELATED ARTICLES

Russia’s COVID-19 Vaccine “Approved for Mass Production” Despite No Phase III Data

News

The scientific community has been left somewhat perplexed today after Russian President Vladamir Putin announced that Russian authorities have approved the world's first COVID-19 vaccine.

READ MORE

Only Around 60% of Recovered COVID-19 Patients Develop Protective Antibodies

News

Scientists have found that only around 60% of patients who have had COVID-19 and recovered from it develop protective antibodies. They also showed that some antibodies even "assist" the virus in infecting host cells.

READ MORE

NIH Announces Clinical Trial To Test Monoclonal Antibodies for COVID-19

News

A Phase 2 clinical trial will evaluate the safety and efficacy of potential new therapeutics for COVID-19, including an investigational therapeutic based on synthetic monoclonal antibodies (mAbs) to treat the disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE